Lantheus Holdings, Inc. (LNTH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1156784,
    "name": "Lantheus Holdings, Inc.",
    "stock_name": "Lantheus Holdings, Inc.",
    "full_name": "Lantheus Holdings, Inc.",
    "name_url": "stocks-analysis/lantheus-holdings-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "61.87",
    "chg": 3.32,
    "chgp": "5.67%",
    "dir": 1,
    "prev_price": "58.55",
    "mcapval": "3,646.53",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US5165441032",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.64 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lantheus-holdings-inc-1156784-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lantheus Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lantheus-holdings-valuation-grade-downgraded-from-attractive-to-fair-amid-price-decline-3686217",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LantheusHolding_valuationdot_3686217.png",
        "date": "2025-11-10 15:45:25",
        "description": "Lantheus Holdings, Inc. has recently adjusted its valuation, with its stock price at $51.07. Over the past year, the company has faced challenges, reflected in a significant stock return decline. Key financial metrics indicate strong performance, including a favorable valuation compared to industry peers."
      },
      {
        "title": "Is Lantheus Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lantheus-holdings-inc-overvalued-or-undervalued-3637787",
        "imagepath": "",
        "date": "2025-10-21 12:08:58",
        "description": "As of 17 October 2025, Lantheus Holdings, Inc. has moved from fair to attractive in its valuation grade. The company appears to be undervalued, with a P/E ratio of 15, an EV to EBITDA of 10.33, and an impressive ROCE of 56.47%. In comparison, QIAGEN NV has a P/E of 24.20, indicating that Lantheus is trading at a significant discount relative to some of its peers.\n\nAdditionally, while Lantheus has shown strong performance in the past five years with a return of 316.48%, it has struggled recently, with a year-to-date return of -37.85%, compared to the S&P 500's 13.30%. This stark contrast highlights the potential for recovery and growth in Lantheus's valuation moving forward...."
      },
      {
        "title": "Lantheus Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lantheus-holdings-changes-valuation-grade-from-fair-to-attractive-amid-price-fluctuations-3640762",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/LantheusHolding_valuationdot_3640762.png",
        "date": "2025-10-20 16:25:16",
        "description": "Lantheus Holdings, Inc. has recently adjusted its valuation, with its current price at $55.60. The company has shown significant volatility over the past year, with a notable 52-week range. Key financial metrics indicate strong operational efficiency and profitability, positioning Lantheus favorably compared to its industry peers."
      },
      {
        "title": "Is Lantheus Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lantheus-holdings-inc-overvalued-or-undervalued-3634657",
        "imagepath": "",
        "date": "2025-10-20 12:26:22",
        "description": "As of 17 October 2025, Lantheus Holdings, Inc. has moved from a fair to attractive valuation grade, indicating a shift towards being undervalued. The company appears to be undervalued based on its current P/E ratio of 15, significantly lower than the peer average of 24.20 for QIAGEN NV, which is considered fair. Additionally, Lantheus has an EV to EBITDA ratio of 10.33 compared to the industry average, suggesting it is trading at a more favorable valuation relative to its earnings potential.\n\nIn terms of performance metrics, Lantheus boasts a remarkable ROCE of 56.47% and an ROE of 31.84%, reflecting strong operational efficiency and profitability. When compared to its peers, Dentsply Sirona, Inc. has a P/E of 9.91, indicating that Lantheus is positioned competitively in the market. Despite recent challenges, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.85% and 9.36..."
      },
      {
        "title": "Is Lantheus Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lantheus-holdings-inc-overvalued-or-undervalued-3632194",
        "imagepath": "",
        "date": "2025-10-19 12:03:53",
        "description": "As of 17 October 2025, the valuation grade for Lantheus Holdings, Inc. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 15, an EV to EBITDA ratio of 10.33, and a robust ROCE of 56.47%. In comparison, QIAGEN NV has a significantly higher P/E ratio of 24.20, while Bio-Rad Laboratories, Inc. shows a P/E of 16.20, highlighting Lantheus's relative attractiveness in the market.\n\nDespite recent struggles, with a year-to-date return of -37.85% compared to the S&P 500's 13.30%, Lantheus has demonstrated strong long-term performance, with a 5-year return of 316.48% versus the S&P 500's 91.29%. This suggests that while the stock has faced challenges recently, its underlying value and potential for recovery remain compelling...."
      },
      {
        "title": "Is Lantheus Holdings, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lantheus-holdings-inc-technically-bullish-or-bearish-3547362",
        "imagepath": "",
        "date": "2025-09-20 19:53:39",
        "description": "As of 6 August 2025, the technical trend for Lantheus Holdings, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from the weekly and monthly MACD, both of which are bearish. The daily moving averages also confirm a bearish trend. The Bollinger Bands are bearish on both weekly and monthly time frames, and the KST is bearish weekly and mildly bearish monthly. The RSI shows no signal weekly but is bullish monthly, indicating some divergence. \n\nIn terms of performance, Lantheus has underperformed significantly compared to the S&P 500, with a year-to-date return of -42.37% versus the S&P 500's 12.22%, and a one-year return of -52.32% compared to 17.14% for the index...."
      },
      {
        "title": "Is Lantheus Holdings, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-lantheus-holdings-inc-overvalued-or-undervalued-3543752",
        "imagepath": "",
        "date": "2025-09-20 18:27:46",
        "description": "As of 7 July 2025, the valuation grade for Lantheus Holdings, Inc. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears to be undervalued, supported by a P/E ratio of 15, an EV to EBITDA of 10.33, and a robust ROCE of 56.47%. In comparison to peers, Lantheus has a significantly lower P/E ratio than QIAGEN NV, which stands at 24.20, and a more favorable EV to EBITDA ratio compared to Masimo Corp. at 57.21.\n\nDespite recent challenges reflected in the stock's performance, with a YTD return of -42.37% compared to the S&P 500's 12.22%, the long-term outlook remains positive, as evidenced by a remarkable 5Y return of 299.07%. This combination of attractive valuation ratios and strong historical performance suggests that Lantheus Holdings, Inc. is positioned well for future growth...."
      }
    ],
    "total": 12,
    "sid": "1156784",
    "stock_news_url": "https://www.marketsmojo.com/news/lantheus-holdings-inc-1156784"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Lantheus Holdings, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape

2025-11-10 15:45:25

Lantheus Holdings, Inc. has recently adjusted its valuation, with its stock price at $51.07. Over the past year, the company has faced challenges, reflected in a significant stock return decline. Key financial metrics indicate strong performance, including a favorable valuation compared to industry peers.

Is Lantheus Holdings, Inc. overvalued or undervalued?

2025-10-21 12:08:58

As of 17 October 2025, Lantheus Holdings, Inc. has moved from fair to attractive in its valuation grade. The company appears to be undervalued, with a P/E ratio of 15, an EV to EBITDA of 10.33, and an impressive ROCE of 56.47%. In comparison, QIAGEN NV has a P/E of 24.20, indicating that Lantheus is trading at a significant discount relative to some of its peers. Additionally, while Lantheus has shown strong performance in the past five years with a return of 316.48%, it has struggled recently, with a year-to-date return of -37.85%, compared to the S&P 500's 13.30%. This stark contrast highlights the potential for recovery and growth in Lantheus's valuation moving forward....

Lantheus Holdings, Inc. Experiences Revision in Its Stock Evaluation Amid Market Volatility

2025-10-20 16:25:16

Lantheus Holdings, Inc. has recently adjusted its valuation, with its current price at $55.60. The company has shown significant volatility over the past year, with a notable 52-week range. Key financial metrics indicate strong operational efficiency and profitability, positioning Lantheus favorably compared to its industry peers.

Is Lantheus Holdings, Inc. overvalued or undervalued?

2025-10-20 12:26:22

As of 17 October 2025, Lantheus Holdings, Inc. has moved from a fair to attractive valuation grade, indicating a shift towards being undervalued. The company appears to be undervalued based on its current P/E ratio of 15, significantly lower than the peer average of 24.20 for QIAGEN NV, which is considered fair. Additionally, Lantheus has an EV to EBITDA ratio of 10.33 compared to the industry average, suggesting it is trading at a more favorable valuation relative to its earnings potential. In terms of performance metrics, Lantheus boasts a remarkable ROCE of 56.47% and an ROE of 31.84%, reflecting strong operational efficiency and profitability. When compared to its peers, Dentsply Sirona, Inc. has a P/E of 9.91, indicating that Lantheus is positioned competitively in the market. Despite recent challenges, the stock has outperformed the S&P 500 over the past week and month, with returns of 3.85% and 9.36...

Is Lantheus Holdings, Inc. overvalued or undervalued?

2025-10-19 12:03:53

As of 17 October 2025, the valuation grade for Lantheus Holdings, Inc. has moved from fair to attractive, indicating a positive shift in its valuation outlook. The company appears to be undervalued, supported by a P/E ratio of 15, an EV to EBITDA ratio of 10.33, and a robust ROCE of 56.47%. In comparison, QIAGEN NV has a significantly higher P/E ratio of 24.20, while Bio-Rad Laboratories, Inc. shows a P/E of 16.20, highlighting Lantheus's relative attractiveness in the market. Despite recent struggles, with a year-to-date return of -37.85% compared to the S&P 500's 13.30%, Lantheus has demonstrated strong long-term performance, with a 5-year return of 316.48% versus the S&P 500's 91.29%. This suggests that while the stock has faced challenges recently, its underlying value and potential for recovery remain compelling....

Is Lantheus Holdings, Inc. technically bullish or bearish?

2025-09-20 19:53:39

As of 6 August 2025, the technical trend for Lantheus Holdings, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a strong indication from the weekly and monthly MACD, both of which are bearish. The daily moving averages also confirm a bearish trend. The Bollinger Bands are bearish on both weekly and monthly time frames, and the KST is bearish weekly and mildly bearish monthly. The RSI shows no signal weekly but is bullish monthly, indicating some divergence. In terms of performance, Lantheus has underperformed significantly compared to the S&P 500, with a year-to-date return of -42.37% versus the S&P 500's 12.22%, and a one-year return of -52.32% compared to 17.14% for the index....

Is Lantheus Holdings, Inc. overvalued or undervalued?

2025-09-20 18:27:46

As of 7 July 2025, the valuation grade for Lantheus Holdings, Inc. has moved from expensive to attractive, indicating a shift towards a more favorable assessment. The company appears to be undervalued, supported by a P/E ratio of 15, an EV to EBITDA of 10.33, and a robust ROCE of 56.47%. In comparison to peers, Lantheus has a significantly lower P/E ratio than QIAGEN NV, which stands at 24.20, and a more favorable EV to EBITDA ratio compared to Masimo Corp. at 57.21. Despite recent challenges reflected in the stock's performance, with a YTD return of -42.37% compared to the S&P 500's 12.22%, the long-term outlook remains positive, as evidenced by a remarkable 5Y return of 299.07%. This combination of attractive valuation ratios and strong historical performance suggests that Lantheus Holdings, Inc. is positioned well for future growth....

View All News